IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Bone Marrow Failure
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinsmonoclonal_antibodyPhase 2/3Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
25 Active assets in the Bone Marrow Failure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Fred Hutchinson Cancer Center | Phase 2/3 | BBB |
Cyclophosphamide Memorial Sloan Kettering Cancer Center | Phase 2/3 | BBB |
Thiotepa Fred Hutchinson Cancer Center | Phase 2 | BB |
Busulphan Memorial Sloan Kettering Cancer Center | Phase 2/3 | BB |
METHOTREXATE Fred Hutchinson Cancer Center | Phase 2 | BB |
View all 37 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →